| 
																	
																	
																		 Connection
 
																		 Laura Dunn to Cognition Disorders  
																		
																	 
																		This is a "connection" page, showing publications Laura Dunn has written about Cognition Disorders.   
																		
																	 
																			
																					
	
						
				
		
			
			
			|  | 
				
					|  | Connection Strength |  |  
					|  |   |  |  
					|  | 1.143 |  |  |  |  
		
		
			
				Dunn LB, Kim JP, Rostami M, Mondal S, Ryan K, Waraich A, Roberts LW, Palmer BW. Stakeholders' Perspectives regarding Participation in Neuromodulation-Based Dementia Intervention Research. J Empir Res Hum Res Ethics. 2022 Feb-Apr; 17(1-2):29-38.	
				
				
					Score: 0.678
				
				Burton CZ, Twamley EW, Lee LC, Palmer BW, Jeste DV, Dunn LB, Irwin SA. Undetected cognitive impairment and decision-making capacity in patients receiving hospice care. Am J Geriatr Psychiatry. 2012 Apr; 20(4):306-16.	
				
				
					Score: 0.087
				
				Irwin SA, Zurhellen CH, Diamond LC, Dunn LB, Palmer BW, Jeste DV, Twamley EW. Unrecognised cognitive impairment in hospice patients: a pilot study. Palliat Med. 2008 Oct; 22(7):842-7.	
				
				
					Score: 0.068
				
				Mittal D, Palmer BW, Dunn LB, Landes R, Ghormley C, Beck C, Golshan S, Blevins D, Jeste DV. Comparison of two enhanced consent procedures for patients with mild Alzheimer disease or mild cognitive impairment. Am J Geriatr Psychiatry. 2007 Feb; 15(2):163-7.	
				
				
					Score: 0.061
				
				Dunn LB, Palmer BW, Keehan M, Jeste DV, Appelbaum PS. Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument. Am J Psychiatry. 2006 Mar; 163(3):500-6.	
				
				
					Score: 0.057
				
				Dunn LB. Capacity to consent to research in schizophrenia: the expanding evidence base. Behav Sci Law. 2006; 24(4):431-45.	
				
				
					Score: 0.056
				
				Palmer BW, Dunn LB, Appelbaum PS, Jeste DV. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia. Arch Gen Psychiatry. 2004 Mar; 61(3):230-6.	
				
				
					Score: 0.049
				
				Dunn LB, Jeste DV. Enhancing informed consent for research and treatment. Neuropsychopharmacology. 2001 Jun; 24(6):595-607.	
				
				
					Score: 0.041
				
				Jeste DV, Palmer BW, Golshan S, Eyler LT, Dunn LB, Meeks T, Glorioso D, Fellows I, Kraemer H, Appelbaum PS. Multimedia consent for research in people with schizophrenia and normal subjects: a randomized controlled trial. Schizophr Bull. 2009 Jul; 35(4):719-29.	
				
				
					Score: 0.016
				
				Jeste DV, Palmer BW, Appelbaum PS, Golshan S, Glorioso D, Dunn LB, Kim K, Meeks T, Kraemer HC. A new brief instrument for assessing decisional capacity for clinical research. Arch Gen Psychiatry. 2007 Aug; 64(8):966-74.	
				
				
					Score: 0.016
				
				Palmer BW, Dunn LB, Depp CA, Eyler LT, Jeste DV. Decisional capacity to consent to research among patients with bipolar disorder: comparison with schizophrenia patients and healthy subjects. J Clin Psychiatry. 2007 May; 68(5):689-96.	
				
				
					Score: 0.015
				 | 
																	
																		
																			
																					              Connection Strength             
  The connection strength for concepts is the sum of the scores for each matching publication.
 Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
 |